Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Th1, Th2, Th17 Phenotype in Urea Cycle Disorders

NCT05706714 is registered in ClinicalTrials.gov with Istanbul University - Cerrahpasa as lead sponsor.

NCT NCT05706714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05706714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Th1, Th2, Th17 Phenotype in Urea Cycle Disorders
Lead sponsor
Istanbul University - Cerrahpasa
Phase
Observational
Overall status
Completed
Start date
April 6, 2021
Completion date
September 1, 2023
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lysinuric protein intolerance, urea cycle disorder